P-232 Effectiveness of anti-B-cell maturation antigen (BCMA)-targeting therapy after selinexor treatment

Baljevic, M., Moreau, P., Tuchman, S., Callander, N., Lentzsch, S., Van Domelen, D., Bentur, O., Monge, J., & Biran, N. (2023). P-232 Effectiveness of anti-B-cell maturation antigen (BCMA)-targeting therapy after selinexor treatment. Clinical Lymphoma Myeloma and Leukemia, 23, S163. https://doi.org/10.1016/s2152-2650(23)01850-5
Authors:
Muhamed Baljević
Philippe Moreau
Sascha A. Tuchman
Natalie S. Callander
Suzanne Lentzsch
Dane R. Van Domelen
Ohad S. Bentur
Jorge Monge
Noa Biran
Affiliated Authors:
Suzanne Lentzsch
Publication Type:
Article
Unique ID:
10.1016/s2152-2650(23)01850-5
Publication Date:
Data Source:
OpenAlex

Record Created: